Abstract
Background
Juvenile hormones (JH) regulate development and reproductive maturation in insects. JHs are synthesized through the mevalonate pathway (MVAP), an ancient metabolic pathway present in the three domains of life. Mevalonate kinase (MVK) is a key enzyme in the MVAP. MVK catalyzes the synthesis of phosphomevalonate (PM) by transferring the γ-phosphoryl group from ATP to the C5 hydroxyl oxygen of mevalonic acid (MA). Despite the importance of MVKs, these enzymes have been poorly characterized in insects.
Results
We functionally characterized an Aedes aegypti MVK (AaMVK) expressed in the corpora allata (CA) of the mosquito. AaMVK displayed its activity in the presence of metal cofactors. Different nucleotides were used by AaMVK as phosphoryl donors. In the presence of Mg2+, the enzyme has higher affinity for MA than ATP. The activity of AaMVK was regulated by feedback inhibition from long-chain isoprenoids, such as geranyl diphosphate (GPP) and farnesyl diphosphate (FPP).
Conclusions
AaMVK exhibited efficient inhibition by GPP and FPP (Ki less than 1 μM), and none by isopentenyl pyrophosphate (IPP) and dimethyl allyl pyrophosphate (DPPM). These results suggest that GPP and FPP might act as physiological inhibitors in the synthesis of isoprenoids in the CA of mosquitoes. Changing MVK activity can alter the flux of precursors and therefore regulate juvenile hormone biosynthesis.
Introduction
Juvenile hormones (JH) play a central role in insect development and reproduction [1]. JHs are sesquiterpenoids biosynthesized de novo by the corpora allata (CA), a pair of endocrine glands connected to the brain [2, 3]. The biosynthetic pathway of JH III involves 13 discrete enzymatic reactions and it is conventionally divided into early (mevalonic acid pathway—MVAP-) and late (JH-branch) steps.
Mevalonate kinase (MVK) is a key enzyme in the MVAP. MVKs (EC 2.7.1.36) are found in the three domains of life as homodimeric proteins [4–7]. They are members of the “GHMP kinase family”, a group of sugar kinases that originally included galactokinases, homoserine kinases, mevalonate kinases, and phosphomevalonate kinases [8, 9]. These enzymes catalyze the synthesis of phosphomevalonate (PM) by transferring the γ-phosphoryl group from ATP to the C5 hydroxyl oxygen of mevalonic acid (MA) in the presence of a divalent cation [10]. They are involved in the production of cholesterol in mammals [11], as well as JHs in insects. MVK deficiency results in human diseases such as mevalonic aciduria and hyperimmunoglobulinemia D/periodic fever syndrome [12].
The activity of MVK is an important regulatory point in the mevalonate pathway in bacteria [6] and eukaryotes [13]. Previous studies have shown that MVKs are subject to inhibition by MVAP intermediates, such as farnesyl pyrophosphate (FPP) and geranyl pyrophosphate (GPP), which may limit isoprenoid production [13–15]. FPP and GPP exert a competitive inhibition at the ATP binding site of MVK [13, 16]; with greater sensitivity to feedback inhibition in eukaryotic enzymes (Ki = 34 nM) than bacterial (Ki = 44 μM) and archaeal (Ki = 34 μM) enzymes [17, 18]. The diversity of inhibitory mechanisms has permitted the classification of MVKs into three distinct classes. MVK class I are inhibited by metabolites downstream of the diphosphomevalonate carboxylase reaction (IPP, DMAPP, GPP, FPP and longer chain isoprenoids), MVK class II are inhibited by diphosphomevalonate (DPM), but not by metabolites downstream of diphosphomevalonate carboxylase, and MVK class III are not inhibited by isoprenoids [18]. High expression of MVK transcripts has been described in the CA of several insect species, including A. aegypti [19–21]; however, the catalytic properties of these enzymes have been poorly characterized. A MVK from Sarcophaga bullata was partially characterized, showing low affinities for MA and ATP [22].
We characterized a MVK expressed in the CA of the mosquito Aedes aegypti (AaMVK). The recombinant AaMVK displays a strong feedback inhibition by long chain isoprenoids, such as geranyl-geranyl pyrophosphate (GGPP), FPP and GPP; with Ki values of less than 1 μM. The endogenous activity of AaMVK was also strongly inhibited by adding long chain isoprenoids to crude extract of mosquito thoraces (containing the CA). Homology modeling was used to build the structure of AaMVK, which revealed the characteristic GHMP kinase domains, as well as the key amino acids involved in substrate binding and catalytic activity.
Materials and Methods
Chemicals
Geranyl-geranyl pyrophosphate (GGPP), farnesyl pyrophosphate (FPP), geranyl pyrophosphate (GPP), isopentenyl pyrophosphate (IPP), dimethyl allyl pyrophosphate (DMAPP) and farnesol (FOL) were purchased from Echelon Biosciences (Salt Lake City, UT). Mevalonic acid (MA), phosphomevalonate (PM), diphosphomevalonate (DPM), phosphoenolpyruvate (PEP) and nicotinamide adenine dinucleotide reduced (NADH) were purchased from Sigma-Aldrich (St. Louis, MO). Pyruvate kinase (PK) and lactate dehydrogenase (LDH) were purchased from LEE biosciences (Maryland Heights, MO).
Insects
A. aegypti of the Rockefeller strain were reared at 28°C and 80% relative humidity under a photoperiod of 16 h light: 8 h dark. A cotton pad soaked in 3% sucrose solution was provided to adults.
Sequence analysis and homology modeling
Sequences similarity searches were performed using the alignment tool BLAST [23]. MVK amino acid sequences were obtained from the National Center of Biotechnology Information and Vector Base. Analyses of degrees of similarity among sequences were performed using the ClustalW tool [24]. AaMVK secondary structure was predicted using PDBsum [25]. Amino acid sequence alignments were performed using Muscle [26]. Motifs from aligned sequences were selected, and consensus sequence logos were built using Weblogo [27]. AaMVK tertiary structure was modeled using the protein structure homology-modeling server Swiss v.8.05 and rat MVK (PDB code 1KVK) as template.
Expression of recombinant A. aegypti mevalonate kinase
The AaMVK cDNA was expressed in E. coli cells as described by Nyati et al. [28]. Recombinant His-tagged proteins were purified using HiTrap affinity columns and PD-10 desalting columns (Amersham Pharmacia, Piscataway, NJ). Glycerol was added to the enzyme solution (final concentration 50%), and samples were stored at -20°C until used. Protein concentrations were determined using the bicinchoninic acid (BCA) protein assay reagent (Pierce, Rockford, IL). Bovine serum albumin was used as a standard.
Enzyme assays
The catalytic activity of AaMVK was measured indirectly using a spectrophotometric assay that couples ADP formation to pyruvate synthesis and reduction to lactate [17, 18]. The disappearance of NADH (measured at 340 nm) serves as a measurement for the phosphorylation of MA by MVK. Samples were incubated for 10 min at 30°C. Each 100 μl reaction mixture contained 0.5 mM phosphoenolpyruvate, 0.01 mM DTT, 0.35 mM NADH, 10 mM MgCl2, 2 units of LDH, and 2 units of PK in 100 mM Tris-HCl pH 7.6. Phosphorylation of MVA was analyzed in reactions containing ATP (250 μM) and MA (200 μM). Assays were performed in triplicate in 96-well plates (BioTek, Winooski, VT).
Reaction products from the catalytic activity of AaMVK were evaluated by reverse-phase HPLC (RP-HPLC). Briefly, recombinant protein (150 ng) was incubated for 1 h in the reaction buffer (100 mM Tris-HCl pH 7.5, 10 mM MgCl2, 0.5 mM DTT) containing: MA (200 μM) and ATP (250 μM). Reactions were terminated by adding 500 μl of acetonitrile, vortexed for 1 min, and centrifuged at 14,000 rpm for 5 min. The organic phase containing PM was recovered, filtered and analyzed by RP-HPLC on a Dionex Summit System (Dionex, Sunnyvale, CA) as previously described [28]. Water and glycerol were used in place of recombinant enzyme as negative controls.
Kinetic parameters
The Michaelis-Menten constant for MA (K m-MA) was determined at a saturating concentration of ATP (5 mM), with MA concentrations ranging from 0.005 to 2.5 mM. Reactions were initiated with the addition of 150 ng of recombinant AaMVK. The K m-ATP was determined using saturating concentrations of MA (1.25 mM) and ATP concentrations ranging from 0.005 to 5 mM. The amount of NADH oxidized to NAD+ was monitored at 340 nm. To determine steady-state kinetic parameters, data were subjected to nonlinear regression fits to the Michaelis—Menten equation using the GraphPad Prism software (San, Diego, CA).
Inhibition studies were performed in triplicate by adding different MVAP intermediates (DPM, DMAPP, IPP, GPP and FPP) to the reaction mix, as well as GGPP at various concentrations (0–1 μM). Inhibition constants (K i) for GPP, FPP and GGPP were calculated after multi-curve fits using the GraphPad Prism software.
AaMVK activity in extracts of mosquito thoraces
Mevalonate kinase activities in thoraces of female adult mosquitoes were measured by monitoring the production of PM using RP-HPLC. Thoraces from 24h old 3% sugar-fed females were dissected in Aedes physiological saline (APS) (138 mM NaCl, 8.4 mM KCl, 4 mM CaCl2, 2 mM MgCl2, 12 mM Na2HPO4 and 42.5 mM sucrose), and transferred to a buffer solution (100 mM Tris-HCl pH 7.5, 10 mM MgCl2, 0.01 mM DTT). Thoraces were homogenized for 1 min, sonicated 3 min and centrifuged at 10,000 g for 10 min at 4°C. Supernatants were recovered and used as crude extract (CE) for activity assays as previously described [29]. The protein contents of the CE were measured using the BCA assay. Enzymatic assays were performed using 4 mg of protein as previously described. Boiled crude extract and reactions without enzyme were included as controls. A standard curve was constructed for the quantification of PM.
IPP in CE were measured by RP-HPLC after conversion into the corresponding alcohol by treating samples with 50 μL of 2.5 N HCl for 10 min [30]. Afterward, 500 μL of hexane were added, samples were vortexed for 1 min and centrifuged at 14, 000 rpm for 10 min at 4°C. Organic phases (containing the alcohols) were recovered, filtered through a 0.2 μm nylon filter and quantified by RP-HPLC.
Statistical analysis
Statistical analyses were performed using the GraphPad Prism Software (San Diego, CA, USA). The results are expressed as means ± S.E.M. Significant differences (P < 0.05) were determined with a one-tailed Student’s t-test or one-way ANOVA followed by a pair-wise comparison of means (Tukey’s test).
Results
Molecular characterization of A. aegypti MVK
The full-length AaMVK open reading frame is 1818 bp long (AAEL006435) [31, 32], and encodes a 397-aa protein with a calculated molecular mass of 43.27 kDa and a pI of 5.8. Amino acid sequence alignments of MVKs from insect and vertebrate species revealed 30–44% similarities (S1 Fig). The three conserved motifs that characterize MVKs were highly conserved among all the sequences analyzed, corroborating the functional role of AaMVK as a kinase (Fig 1). Motif I: containing part of the active site (PGKVILXGEHSVVXXXPA); motif II: a conserved glycine-rich motif (SIGXGLGSSAG) that forms a phosphate-binding loop in all GHMP kinases, and motif III: a conserved amino acid sequence (KLTGAGGGGC) that stabilizes the phosphate binding loop [5, 9].
Structural analysis of the active site of AaMVK
The molecular model of AaMVK was built by homology modeling using the rat MVK (PDB: 1kvk), which exhibited 32.7% identity to AaMVK, as template (Fig 2). The analysis of the AaMVK structure revealed a fold consisting of a mixture of α-helices and β-sheets (S2 Fig). The N-terminal domain is composed of ten β sheets and eight α- helices and the C-terminal domain is composed of four helices and two β sheets. The larger N- terminal (include amino acids 1 to 246, 358 to 397) and the smaller C-terminal (include amino acids 247 to 357) domains are arranged in a V-shape that creates a central cleft, with the AaMVK ligand binding pocket, composed by Lys14, Ser159, Glu208, and Asp219, located at the cleft between the two domains. Similar structures have been previously described for other MVKs [4, 5, 33].
Functional characterization of AaMVK
The recombinant AaMVK was isolated from E.coli extracts by affinity chromatography, and identified using an anti-His antibody (S3 Fig) as previously described [28]. Optimal catalytic conditions were initially established for AaMVK. The recombinant enzyme displayed activity on a broad range of pH values, with the highest activity at pH 7.5–8.0 (S4 Fig). The catalytic activity of recombinant AaMVK increased in a dose response manner when Mg2+ was used as a cofactor. Mn2+ and Co2+ also enhanced MVK activity to a lesser degree than Mg2+ (Fig 3A).
The nucleotide specificity of AaMVK was measured in the presence of different triphosphates phosphoryl donors. Relative rates of MVK activity when ATP, GTP, TTP and CTP were used were 100, 15, 11 and 5 percent respectively (Fig 3B).
Kinetic analyses of AaMVK
AaMVK showed normal Michaelis-Menten kinetics, which were obtained using a range of ATP concentrations and a fixed mevalonic acid (MA). The apparent Km ATP was 140 ± 28 μM. Measurements using a fixed ATP concentration and MA levels that ranged from 0.005 to 2.5 mM indicated that the apparent Km MA was 90 ± 18 μM. Km values for MA were comparable to those previously described in archaea, bacteria and eukaryotes (Table 1).
Table 1. Kinetics parameters of eukaryotic, bacterial and archaeal MVKs.
Species | Km MA (μM) | Km ATP (μM) | Vmax (μmol min-1 mg-1) | Kcat (s-1) | Ki GPP (μM) | Ki FPP (μM) | Reference |
---|---|---|---|---|---|---|---|
A. aegypti | 90 | 140 | 33 | 10.1 | 0.55 | 0.44 | This Work |
S. bullata | 620 | 4700 | ND | ND | ND | ND | [22] |
R. norvergicus | 35 | 950 | 39 | 21.9 | ND | 2.50 | [41] |
H. sapiens | 150 | 440 | 14 | ND | 0.11 | 0.10 | [13] |
S. pneumonia | 236 | 372 | ND | 11.0 | NI | NI | [18] |
S. aureus | 41 | 339 | 12 | ND | ND | >10 | [42] |
M. jannaschii | 106 | 1180 | 50 | 28.5 | >10 | >10 | [41] |
M. mazei | 68 | 464 | ND | 4.3 | NI | NI | [18] |
ND: Not Determined; NI: not inhibitory.
Inhibition of AaMVK by long-chain isoprenoids
The sensitivity of AaMVK towards several phosphorylated isoprenoids is shown in Fig 4 and Table 1. AaMVK activity was strongly inhibited by long chain isoprenoids. Our results demonstrated that GGPP, FPP and GPP are competitive inhibitors for the binding of ATP to AaMVK. Their inhibitory capacities (Ki) were: GGPP (0.93 ± 0.19 μM), FPP (0.44 ± 0.2 μM) and GPP (0.55 ± 0.28 μM) (S5 Fig). Short chain isoprenoids, such as DMAPP and IPP inhibited only in the micromolar range, with a K i value greater than 10 μM; while C6 compounds, such as PM and DPM, were not inhibitory.
AaMVK activity in extracts of mosquito thoraces
To further assess the inhibitory feedback of isoprenoid on AaMVK, we analyzed the MVK activity in homogenates of mosquito thoraces that contained the CA (24h old sugar-fed females), in the presence of 100 μM FPP. Addition of FPP resulted in a 25% reduction of MVK activity (Fig 5A). When we analyzed the reactions products from the activity of enzymatic extracts from mosquito thoraces on MA, we observed a significant increase in isopentenyl pyrophosphate (IPP) concentration. Since MVK, phosphomevalonate kinase and mevalonate diphosphate decarboxylase share similar reaction conditions [34], these results suggested that in our in vitro assay using mosquito homogenates the catalytic transformation of MA into PM continue to generate IPP via diphosphomevalonate (DPM). Changes in the IPP concentration were therefore used as a proxy to study the effect of FPP on MVK activity in mosquito thoraces homogenates. An inhibitory effect of FPP on MVK was confirmed, with the levels of IPP significantly reduced when FPP was added to the extracts, compared to those that were not exposed to FPP (Fig 5B).
Discussion
The JHs are synthesized through the MVAP, an ancient metabolic pathway present in the three domains of life [7]. The MVAP consists of a main trunk followed by sub-branches that generate a diverse range of essential biomolecules required for cell signaling, membrane integrity, energy homeostasis, protein prenylation and glycosylation [35–38]. Insects lack the cholesterol-synthetic branch present in vertebrates [39], but in the CA the MVAP branches into the synthesis of JH.
Mevalonate kinase is one of three consecutive ATP-dependent enzymes in the MVAP. The primary structure of AaMVK revealed all the characteristic GHMP kinase domains (Pfam: 00288 and Pfam08544), as well as the key amino acids involved in substrate binding and catalytic activity (Lys14, Ser159, Glu208 and Asp219) [16, 40]. The structural analysis confirmed that these residues are situated at the active site [5, 17], suggesting that catalysis in insect is also mediated by a base mechanism [5], in which Asp219 makes a salt bridge with Lys14, with the penta-coordinated γ-phosphate transition state stabilized by Mg2+ and the amino acids Glu208, Ser159 and Lys14. The residue Asp219 acts as a general base, abstracting a proton from the hydroxyl group of MA, therefore converting MA into an excellent nucleophile that attacks the γ-phosphorus of ATP. The residue Lys14 is believed to maintain the aspartate residue in the deprotonated state to facilitate the proton transfer. Several insertions (loops) lying on the surface of the globular structure were identified in the AaMVK. These loops do not contain any catalytic amino acid, but as it has been suggested that might be important conferring protein stability [5]. Although disulfide bridges confer thermostability to prokaryote MVKs [41], the absence of disulfide bridges is another important feature that the AaMVK shares with other eukaryotic MVKs.
Like many ATP-dependent reactions, AaMVK requires divalent metal cations for catalysis. The function of the divalent metal cation is to anchor the diphosphate moieties and to facilitate ionization of allylic substrates [18]. Although in insects it seems that the essential cation in vivo is Mg2+, our results shown that AaMVK can replace Mg2+ in vitro by other divalent cations such as Mn2+ and Co2+. Similarly, in the process of phosphorylation, although other nucleotide triphosphates including GTP, CTP and TTP can partially substitute for ATP as phosphoryl donors in vitro, most likely ATP is the preferential in vivo phosphoryl donor. The results for the analysis of cofactor requirements, phosphoryl source and optimal pH of AaMVK were in agreement with those described for previously characterized MVKs [42, 43]. Our kinetic studies revealed that the Vmax for the formation of PM in mosquitoes was comparable to that described for other MVK’s, ranging from 12 to 50 μmol min-1 mg-1 (Table 1). The AaMVK Michaelis-Menten constants for mevalonate (Km MA) and ATP (Km ATP) were in the range of those previously described for other MVKs (Table 1), which also have higher affinity for MA than ATP. Comparisons of kinetics between purified and recombinant enzymes are not always straightforward; much more difficult is to compare their activities with those of crude extracts. Discrepancies between the kinetic properties of purified and recombinant enzymes from the same species have been reported for other MVP enzymes [44]. Conclusive evidence linking the activity of the recombinant AaMVK with the activity detected in extracts is missing; but the fact that AaMVK is a highly conserved protein, encoded by a single annotated gene in the A. aegypti genome, and with transcripts enriched in the CA [20], suggest that both activities correspond to the same protein.
AaMVK mRNA expression levels in the CA are concurrent with JH biosynthesis titers in female mosquitoes [20, 31]. MVK transcripts in Bombyx mori also correlate with JH synthesis [19], suggesting an important role of this enzyme in the regulation of the JH pathway. The mevalonate pathway is subject to multivalent transcriptional and post-transcriptional regulation, primarily at the level of HMG-CoA reductase [35]; however, it is becoming increasingly clear that regulation of MVK catalysis plays also an important modulatory role. A regulatory mechanism for controlling MVK activity is feedback inhibition by the presence of isoprenoids [17, 42, 45]. The competitive inhibition results from the interaction of the isoprenoid binding site of the phosphoryl group of ATP [17].
AaMVK is a class I enzyme, exhibiting efficient inhibition by GPP and FPP (Ki less than 1 μM), and none by IPP and DPPM. It is interesting that the two products of a single enzyme (FPP synthase) are specific in their inhibition of AaMVK. The possibility that GPP and FPP act as physiological inhibitors (in vivo) in the synthesis of JH in mosquito is strengthened when considering the inhibition exerted by these two metabolites on the MVK activity present in crude extracts of female mosquito thoraces containing the CA. However, further analysis are required to evaluate their significance as regulators in vivo.
The activity of AaMVK in the CA of female mosquito shows dramatic changes during the gonotrophic cycle that correlate well with changes in JH biosynthesis [34]. AaMVK activity is very low in newly emerged adult females (30 fmol/CA/h), it increases more than 200 folds by 12 h after adult eclosion (4500 fmol/CA/h), and markedly decreases with the decline of JH synthesis by 24 h after blood feeding (20 fmol/CA/h) [34]. Although rate limiting bottlenecks have been proposed at single specific steps in both the MVAP and JH-branch in the CA of different insects, our previous studies suggested that there are multiple regulatory points and they change in different physiological stages [34, 46]. Further studies will be necessary to reveal if AaMVK plays a key role restricting the flux into JH III at specific physiological conditions.
Supporting Information
Acknowledgments
This work was supported by NIH grant AI 45545 to FGN.
Data Availability
All relevant data are within the paper and its Supporting Information files.
Funding Statement
This work was supported by grant AI 45545, National Institutes of Health, NIAID (to FGN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1. Goodman WG, Cusson M. The Juvenile Hormones In Insect Endocrinology (Gilbert LI, ed.), Elsevier, 2012. pp. 310–365. [Google Scholar]
- 2. Tobe SS, Stay B. Structure and regulation of the corpus allatum . Adv Ins Phys. 1985; 18: 305–431. [Google Scholar]
- 3. Schooley DA, Baker FC. Juvenile hormone biosynthesis In: Kerkut G.A., Gilbert L.I. (Eds.), Comprehensive Ins Physiol Biochem Pharm., vol. 7 Pergamon Press, Oxford, 1985, pp. 363–389. [Google Scholar]
- 4. Yang D, Lance W, Shipman CA, Roessner A, Ian S, James C. Structure of the Methanococcus jannaschii mevalonate kinase, a member of the GHMP kinase superfamily. J Biol Chem. 2002; 277: 9462–9467. [DOI] [PubMed] [Google Scholar]
- 5. Fu Z, Wang M, Potter D, Miziorko HM, Kim JJP. The structure of a binary complex between a mammalian mevalonate kinase and ATP: Insights into the reaction mechanism and human inherited disease. J Biol Chem. 2002; 277: 18134–18142. [DOI] [PubMed] [Google Scholar]
- 6. Andreassi JL, Dabovic K, Leyh TS. Streptococcus pneumonia isoprenoid biosynthesis is downregulated by diphosphomevalonate: An antimicrobial target. Biochemistry. 2004; 43: 16461–16466. [DOI] [PubMed] [Google Scholar]
- 7. Lombard J, Moreira D. Origins and early evolution of the mevalonate pathway of isoprenoid biosynthesis in the three domains of life. Mol Biol Evol. 2010; 28: 87–99. 10.1093/molbev/msq177 [DOI] [PubMed] [Google Scholar]
- 8. Bork P, Sander C, Valencia A. Convergent evolution of similar enzymatic function on different protein folds: The hexokinase, ribokinase and galactokinase families of sugar kinases. Protein Sci. 1993; 2: 31–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Cheek S, Zhang H, Grishin NV. Sequence and structure classification of kinases. J Mol Biol. 2002; 320: 855–881. [DOI] [PubMed] [Google Scholar]
- 10. Tchen TT. Mevalonate kinase: Purification and properties. J Biol Chem. 1958; 233: 1100–1103. [PubMed] [Google Scholar]
- 11. Amdur BH, Rilling H, Bloch K. The enzymatic conversation of mevalonic acid to squalene. J Am Chem Soc. 1957; 79: 2646. [Google Scholar]
- 12. Hoffman G, Gibson KM, Brandt IK, Bader PI, Wappner RS, Sweetman L. Mevalonic Aciduria: An Inborn Error of Cholesterol and Nonsterol Isoprene Biosynthesis. N Engl J Med 1986; 314: 1610–1614. [DOI] [PubMed] [Google Scholar]
- 13. Hinson DD, Chambliss KL, Toth MJ, Tanaka RD, Gibson KM. Post-translational regulation of mevalonate kinase by intermediates of the cholesterol of mevalonate kinase by intermediates of the cholesterol and nonsterol isoprene biosynthetic pathways. J Lipid Res. 1997; 38: 2216–2223. [PubMed] [Google Scholar]
- 14. Tanaka RD, Lee LY, Schafer BL, Kratunis VJ, Mohler WA, Robinson GW, et al. Molecular cloning of mevalonate kinase and regulation of its mRNA levels in rat liver. Proc Natl Acad Sci USA, 1990; 87: 2872–2876. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Beytia EJ, Dorsey KJ, Marr J, Cleland WW, Porter JW. Purification and mechanism of action of hog liver mevalonate kinase. J Biol Chem. 1970; 245: 5450–5458. [PubMed] [Google Scholar]
- 16. Potter D, Miziorko HM. Identification of catalytic residues in human mevalonate kinase. J Biol Chem. 1997; 272: 25449–25454. [DOI] [PubMed] [Google Scholar]
- 17. Fu Z, Voynova NE, Herdenhorf TJ, Miziorko HM, Kim JJ. Biochemical and structural basis for feedback inhibition of mevalonate kinase and isoprenoid metabolism. Biochemistry. 2008; 47: 3715–3724. 10.1021/bi7024386 [DOI] [PubMed] [Google Scholar]
- 18. Primak YA, Du M, Miller MC, Wells DH, Nielsen AT, Weyler W, et al. Characterization of a feedback-resistant mevalonate kinase from the archaeon Methanosarcina mazei. Appl Env Microbiol. 2011; 77: 7772–7778. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Kinjoh T, Kaneko Y, Itoyama K, Mita K, Hiruma K, Shinoda T. Control of juvenile hormone biosynthesis in Bombyx mori: Cloning of the enzymes in the mevalonate pathway and assessment of their developmental expression in the corpora allata . Insect Biochem Mol Biol. 2007; 37: 808–818. [DOI] [PubMed] [Google Scholar]
- 20. Nouzova M, Edwards MJ, Mayoral JG, Noriega FG. A coordinated expression of biosynthetic enzyme controls the flux of juvenile hormone precursors in the corpora allata of mosquitoes. Insect Biochem Mol Biol. 2011; 9: 660–669. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Huang J, Marchal E, Hult EF, Tobe SS. Characterization of the juvenile hormone pathway in the viviparous cockroach, Diploptera punctata. PLoS ONE 2015; 10(2): e0117291 10.1371/journal.pone.0117291 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Goodfellow RD, Barnes FJ. Mevalonate kinase from the larva of the flesh fly, Sarcophaga bullata . Insect Biochem Mol Biol. 1971; 1: 271–282. [Google Scholar]
- 23. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W. et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997; 25: 3389–3402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Larking MA, Blackshields G, Brown NP, Chenna R, McGettingan PA, McWilliam H, et al. ClustalW and ClustalX version 2. Bioinformatics 2007; 21: 2947–2948. [DOI] [PubMed] [Google Scholar]
- 25. Laskowski RA. PDBsum new things. Nucleic Acids Res. 2009; 37: D355–D359. 10.1093/nar/gkn860 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004; 32: 1792–1797. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Crooks GE, Hon G, Chandonia JM, Brenner SE. WebLogo: a sequence logo generator. Genome Res. 2004; 14: 1188–1190. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Nyati P, Nouzova M, Rivera-Perez C, Clifton ME, Mayoral JG, Noriega FG. Farnesyl phosphatase, a corpora allata enzyme involved in juvenile hormone biosynthesis in Aedes aegypti . PLoS ONE 2013; 8(8): e71967 10.1371/journal.pone.0071967 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Rivera-Perez C, Nouzova M, Clifton ME, Martin-Garcia E, LeBlanc E, Noriega FG. Aldehyde dehydrogenase 3 converts farnesal into farnesoic acid in the corpora allata of mosquitoes. Insect Biochem Mol Biol. 2013; 43: 675–682. 10.1016/j.ibmb.2013.04.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Saisho Y, Morimoto A, Umeda T (1997) Determination of farnesyl pyrophosphate in dog and human plasma by high-performance liquid chromatography with fluorescence detection. Anal. Biochem 252: 89–95. [DOI] [PubMed] [Google Scholar]
- 31. Noriega FG, Ribeiro JMC, Koener JF, Valenzuela JG, Hernandez-Martinez S, Pham VM, et al. 2006. Genomic endocrinology of insect juvenile hormone biosynthesis. Insect Biochem. Mol. Biol. 36, 366–374. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Nene V, et al. 2007. Genome sequence of Aedes aegypti, a major arbovirus vector. Science. 316, 1718–1723. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Andreassi JL, Leyh TS. Molecular functions of conserved aspects of the GHMP kinase family. Biochemistry. 2004; 43:14594–14601. [DOI] [PubMed] [Google Scholar]
- 34. Rivera-Perez C, Nouzova M, Lamboglia I, Noriega FG. Metabolic analysis changes in the mevalonate and juvenile hormone synthesis pathways linked to the mosquito reproductive physiology. Insect Biochem Mol Biol. 2014; 51: 1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 1990; 343: 425–430. [DOI] [PubMed] [Google Scholar]
- 36. Holstein SA, Hohl RJ. Isoprenoids: Remarkable diversity of form and function. Lipids 2004; 39: 293–309. [DOI] [PubMed] [Google Scholar]
- 37. McTaggart SJ. Isoprenylated proteins. Cell Mol Life Sci. 2006; 63: 255–267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Vranova E, Coman D, Gruissem W. Network analysis of the MVA and MEP pathways for isoprenoid synthesis. Annu Rev Plant Biol. 2013; 64: 665–700. 10.1146/annurev-arplant-050312-120116 [DOI] [PubMed] [Google Scholar]
- 39. Belles X, Martin D, Piulachs MD. The mevalonate pathway and the synthesis of juvenile hormone in insects. Annu Rev Entomol. 2005; 50: 181–199. [DOI] [PubMed] [Google Scholar]
- 40. Potter D, Wojnar JM, Narasimhan C, Miziorko HM. Identification and functional characterization of an active-site lysine in mevalonate kinase. J Biol Chem. 1997; 272: 5741–5746. [DOI] [PubMed] [Google Scholar]
- 41. Chu X, Yu W, Wu L, Liu X, Li N, Li D. Effect of a disulfide bridge bond on mevalonate kinase. Biochim Biophys Acta. 2007; 1774: 1571–158 [DOI] [PubMed] [Google Scholar]
- 42. Voynova NE, Rios SE, Miziorko HM. Staphylococcus aureus mevalonate kinase: isolation and characterization of an enzyme of the isoprenoid biosynthetic pathway. J Bacteriol. 2003; 186: 61–67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Hedl M, Rodwell VW. Enterococcus faecalis mevalonate kinase. Protein Sci. 2003; 13:687–693. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Ramos-Valdivia AC, van der Heijden R, Verpoorte R, 1997. Isopentenyl diphosphate isomerase: a core enzyme in isoprenoid biosynthesis. A review of its biochemistry and function. Nat. Prod. Rev. 14, 591–603. [DOI] [PubMed] [Google Scholar]
- 45. Dorsery JK, Porter JW. The inhibition of mevalonate kinase by geranyl and farnesyl pyrophosphate. J Biol Chem. 1968; 243: 4667–4670. [PubMed] [Google Scholar]
- 46. Noriega FG. Juvenile hormone biosynthesis in insects: What is new, what do we know, and what questions remain? ISRN 2014, Article ID 967361. 10.1155/2014/967361 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All relevant data are within the paper and its Supporting Information files.